Stephanie V. Blank

ORCID: 0000-0002-5333-9484 · 4 papers in corpus
other 2023
Gynecologic oncology reports ·doi:10.1016/j.gore.2023.101143

Social media outlets have increased in popularity within the last decade and are influencing the ways in which patients interact with the healthcare system. The objective of this study is to examine the presence of gynecologic oncology divi…

case-report 2019
Gynecologic oncology reports ·doi:10.1016/j.gore.2018.12.005

•Breast cancer originating from the vulva is extremely rare.•There are no guidelines for the treatment of such cancers.•More research is needed to uncover a possible genetic predisposition.

nonrandomized-trial 2014
Journal of Clinical Oncology ·doi:10.1200/jco.2013.54.1987

PURPOSE: Risk-reducing salpingo-oophorectomy (RRSO) lowers mortality from ovarian/tubal and breast cancers among BRCA1/2 mutation carriers. Uncertainties persist regarding potential benefits of RRSO among high-risk noncarriers, optimal surg…

observational 2003
International Journal of Gynecological Pathology ·doi:10.1097/00004347-200304000-00006

The proto-oncogene c-kit is a transmembrane-tyrosine-kinase receptor that is structurally related to the platelet-derived growth-factor receptor (PDGFR) and is involved in cell differentiation. C-kit has been found to be expressed in certai…